Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Inflammation mediators, also known as inflammatory mediators, are endogenous chemical agents that play a central role in initiating, regulating, and resolving the inflammatory response. They are produced by various cells—primarily immune cells such as macrophages, neutrophils, lymphocytes, and mast cells—in response to infection, injury, or other harmful stimuli. These substances orchestrate the complex cascade of events that characterize inflammation: vasodilation (increased blood flow), increased vascular permeability (allowing immune cell migration), pain induction, and recruitment of additional immune components to sites of tissue damage or infection. Dysregulation or excessive production can contribute to chronic diseases.
Inflammatory mediators act through several mechanisms: - Inducing vasodilation for increased blood flow - Increasing vascular permeability so immune cells can access affected tissues - Attracting white blood cells via chemotaxis - Activating endothelial and other local tissue responses
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Inflammation Mediator.